Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Jan 1;76(1):123-130.
doi: 10.1093/gerona/glaa111.

Muscle Mass Assessed by the D3-Creatine Dilution Method and Incident Self-reported Disability and Mortality in a Prospective Observational Study of Community-Dwelling Older Men

Affiliations
Observational Study

Muscle Mass Assessed by the D3-Creatine Dilution Method and Incident Self-reported Disability and Mortality in a Prospective Observational Study of Community-Dwelling Older Men

Peggy M Cawthon et al. J Gerontol A Biol Sci Med Sci. .

Abstract

Background: Whether low muscle mass is a risk factor for disability and mortality is unclear. Associations between approximations of muscle mass (including lean mass from dual-energy x-ray absorptiometry [DXA]), and these outcomes are inconsistent.

Methods: Muscle mass measured by deuterated creatine (D3Cr) dilution and appendicular lean mass (ALM, by DXA) were assessed at the Year 14 Visit (2014-2016) of the prospective Osteoporotic Fractures in Men study (N = 1,425, age 77-101 years). Disability in activities of daily living (ADLs), instrumental ADLs, and mobility tasks was self-reported at the Year 14 visit and 2.2 years later; deaths were centrally adjudicated over 3.3 years. Relative risks and 95% confidence intervals (CI) were estimated per standard deviation decrement with negative binomial, logistic regression, or proportional hazards models.

Results: In age- and clinical center-adjusted models, the relative risks per decrement in D3Cr muscle mass/wgt was 1.9 (95% CI: 1.2, 3.1) for incident self-reported ADL disability; 1.5 (95% CI: 1.3, 1.9) for instrumental ADL disability; and 1.8 (95% CI: 1.5, 2.2) for mobility disability. In age-, clinical center-, and weight-adjusted models, the relative risks per decrement in D3Cr muscle mass was 1.8 (95% CI: 1.5, 2.2) for all-cause mortality. In contrast, lower DXA ALM was not associated with any outcome. Associations of D3Cr muscle mass with these outcomes were slightly attenuated after adjustment for confounding factors and the potentially mediating effects of strength and physical performance.

Conclusions: Low muscle mass as measured by D3Cr dilution is a novel risk factor for clinically meaningful outcomes in older men.

Keywords: Death; Disability; Muscle mass.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Age- and clinic center-adjusted relative risk for incident IADL disability and mobility disability, per SD decrement of D3Cr muscle mass/wgt (A) or appendicular lean mass (kg)/height (m2) (B). *Relative risk (95% CI) estimated using logistic regression due to small event counts.
Figure 2.
Figure 2.
Multivariable-adjusted relative risk for incident IADL disability, by quartiles and per SD increment of D3Cr muscle mass/wgt (A, C) or DXA appendicular lean mass (kg)/height (m2) (B, D). Multivariable models adjusted for age, race, clinical center, alcohol use, smoking status, comorbidities, physical activity, percent fat, exhaustion, cognitive function, self-reported health status, and weight change. D3Cr muscle mass/wgt models also adjusted for height (A, B). Models further adjusted for strength and physical performance covariates also include chair stands, gait speed, and grip strength (C, D).
Figure 3.
Figure 3.
Multivariable-adjusted relative risk for incident mobility disability, by quartiles and per SD increment of D3Cr muscle mass/wgt (A, C) or DXA appendicular lean mass(kg)/height (m2) (B, D). Multivariable models adjusted for age, race, clinical center, alcohol use, smoking status, comorbidities, physical activity, percent fat, exhaustion, cognitive function, self-reported health status and weight change. D3Cr muscle mass/wgt models also adjusted for height (A, B). Models further adjusted for strength and physical performance covariates also include chair stands, gait speed, and grip strength (C, D).
Figure 4.
Figure 4.
Multivariable-adjusted hazard ratio for all-cause mortality, by quartiles of D3Cr muscle mass (A, C) or DXA appendicular lean mass(kg) (B, D). Multivariable models adjusted for age, race, clinical center, alcohol use, smoking status, comorbidities, physical activity, percent fat, exhaustion, cognitive function, self-reported health status, weight change, weight, and height (A, B). Models further adjusted for strength and physical performance covariates also include chair stands, gait speed, and grip strength (C, D).

References

    1. Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults. JAMA. 2011;305:50–58. doi:10.1001/jama.2010.1923 - DOI - PMC - PubMed
    1. Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 1995;332:556–561. doi:10.1056/NEJM199503023320902 - DOI - PMC - PubMed
    1. Rantanen T, Guralnik JM, Foley D, et al. Midlife hand grip strength as a predictor of old age disability. JAMA. 1999;281:558–560. doi:10.1001/jama.281.6.558 - DOI - PubMed
    1. Wu Y, Wang W, Liu T, Zhang D. Association of grip strength with risk of all-cause mortality, cardiovascular diseases, and cancer in community-dwelling populations: a meta-analysis of prospective cohort studies. J Am Med Dir Assoc. 2017;18(6):551.e17–e35. doi:10.1016/j.jamda.2017.03.011 - DOI - PubMed
    1. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147:755–763. doi:10.1093/oxfordjournals.aje.a009520 - DOI - PubMed

Publication types